Chandrasekaran S, Ling YL, Tang J. Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States. Melanoma Res 2024 Jul 16. doi: 10.1097/CMR.0000000000000990.
PMID: 39012389